This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Imaizumi, M. Articles by Eguchi, K. Search for Related Content PubMed PubMed Citation Articles by Imaizumi, M. Articles by Eguchi, K. Related Collections Thyroid Endocrine Oncology

Long-Term Prognosis of Thyroid Nodule Cases Compared with Nodule-Free Controls in Atomic Bomb Survivors

Departments of Clinical Studies (M.I., M.A., K.A., S.I., A.H., M.S., R.M.) and Statistics (E.N.), Radiation Effects Research Foundation, Nagasaki 850-0013, Japan; First Department of Internal Medicine (M.I., T.U., R.I., E.E., K.E.), Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan; Department of Internal Medicine (T.T.), Sasebo Chuo Hospital, Nagasaki 857-1195, Japan; and Japan Radioisotope Association (S.N.), Tokyo 113-8941, Japan

Address all correspondence and requests for reprints to: Misa Imaizumi, M.D., Radiation Effects Research Foundation, 1-8-6 Nakagawa, Nagasaki 850-0013, Japan. E-mail: misaima{at}rerf.or.jp.

Context: Radiation exposure is associated with development of thyroid nodules. The long-term risk of thyroid cancer development in irradiated people with thyroid nodules, however, has not been clarified.

Objective: The objective of this study was to assess the long-term risk of cancer development in irradiated individuals with thyroid nodules.

Design, Setting, and Participants: This prospective study comprised 2637 atomic bomb survivors (mean age, 59 yr; 1071 men and 1566 women) who participated in the baseline thyroid study of the Nagasaki Radiation Effects Research Foundation from 1984 through 1987. The participants were divided into three groups at baseline by ultrasound findings: 82 cases of solid thyroid nodules other than cancer, 121 cases of thyroid cysts, and 2434 thyroid nodule-free controls. Both the solid nodule and the cyst groups included postoperative cases. In the solid nodule group, 68 cases had ultrasound-detected solid nodules, including 31 cases diagnosed as benign by cytological or histological examination. They were followed for an average of 13.3 yr.

Main Outcome Measure: Incident thyroid cancer was measured during an average 13.3-yr follow-up period.

Results: During the follow-up period, six thyroid cancer cases (7.3%) were found in the solid nodule group, seven cases in the controls (0.3%), and one case (0.8%) in the cyst group. In 31 cases with solid nodules diagnosed as benign, three cases (9.7%) developed thyroid cancer. The hazard ratio (HR) for cancer development was significantly high at 23.6 [95% confidence interval (CI), 7.6–72.8] in the solid nodule group (HR, 40.2; 95% CI, 9.4–173.0 in 31 people with solid nodules diagnosed as benign) but not in the cyst group (HR, 2.7; 95% CI, 0.3–22.2), after controlling for age and sex. Sex, age, TSH level, thyroglobulin level, radiation dose, nodule volume, and increase in nodule volume did not predict cancer development in the solid nodule group.

Conclusions: Risk of thyroid cancer development is high in atomic bomb survivors with solid thyroid nodules, suggesting the need for careful observation of irradiated individuals with such nodules.

This article has been cited by other articles:

				D. V. Mihailescu and A. B. Schneider Size, Number, and Distribution of Thyroid Nodules and the Risk of Malignancy in Radiation-Exposed Patients Who Underwent Surgery J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2188 - 2193. [Abstract] [Full Text] [PDF]

				M. Imaizumi, K. Ashizawa, K. Neriishi, M. Akahoshi, E. Nakashima, T. Usa, T. Tominaga, A. Hida, N. Sera, M. Soda, et al. Thyroid Diseases in Atomic Bomb Survivors Exposed in Utero J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1641 - 1648. [Abstract] [Full Text] [PDF]

				D. L. Preston, H. Cullings, A. Suyama, S. Funamoto, N. Nishi, M. Soda, K. Mabuchi, K. Kodama, F. Kasagi, and R. E. Shore Solid Cancer Incidence in Atomic Bomb Survivors Exposed In Utero or as Young Children J Natl Cancer Inst, March 19, 2008; 100(6): 428 - 436. [Abstract] [Full Text] [PDF]

				J. K. Hoang, W. K. Lee, M. Lee, D. Johnson, and S. Farrell US Features of Thyroid Malignancy: Pearls and Pitfalls RadioGraphics, May 1, 2007; 27(3): 847 - 860. [Abstract] [Full Text] [PDF]